Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 66Terminated 15Recruiting 4Active not recruiting 4Not yet recruiting 3Withdrawn 2Unknown 2No longer available 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Sarcoma 1Myeloid 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Gastrointestinal Stromal Tumors 1

Interventions

Injections 41Carboplatin 34Cisplatin 24Capecitabine 24Paclitaxel 23Docetaxel 23pembrolizumab 21Oxaliplatin 21Gemcitabine 20Pemetrexed 19Bevacizumab 18Fluorouracil 13Irinotecan 12Cyclophosphamide 12osimertinib 9Nivolumab 8Dexamethasone 8tislelizumab 7Topotecan 7Leucovorin 7Doxorubicin 7130-nm albumin-bound paclitaxel 7venetoclax 6toripalimab 6regorafenib 6lenvatinib 6fludarabine 6Rituximab 6Cetuximab 6daratumumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Imatinib Mesylate × Clear all
NCT07585266 2026-05-13

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

GlaxoSmithKline

Phase 3 Not yet recruiting
800 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07091019 2025-07-29

ASC4REAL-2

Novartis

Not yet recruiting
1,000 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 4 Not yet recruiting
2,400 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡